Feeding, Swallowing, and GI Issues – Non-Sitters

Feeding, Swallowing, and GI Issues – Non-Sitters

Feeding and swallowing are among the chief concerns for families and healthcare providers on non-sitters with spinal muscular atrophy (SMA).1 Bulbar muscle dysfunction affects the laryngeal and pharyngeal muscles, which can interfere with the ability to swallow and...
Nusinersen

Nusinersen

Nusinersen (Spinraza) is the first FDA-approved, disease-modifying therapy for the treatment of spinal muscular atrophy (SMA). Nusinersen is an antisense oligonucleotide that binds to a sequence downstream of exon 7 in the SMN2 gene. The oligonucleotide blocks the...